Skip to content

Exagen Inc. XGN Asset turnover

Asset turnover at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
0.8×0.0×
Quest Diagnostics logo
Quest DiagnosticsDGX
0.7×0.0×
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-0.1×
CareDx logo
CareDxCDNA
0.9×+0.2×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
0.3×0.0×
Revvity logo
RevvityRVTY
0.2×0.0×

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Calculated from Exagen Inc.’s reported figures.

Based on trailing twelve months.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s asset turnover?
Exagen Inc. (XGN) reported asset turnover of 1.5× in Q1 2026.
How has Exagen Inc.'s asset turnover changed year-over-year?
Exagen Inc.'s asset turnover increased by 19.0% year-over-year, from 1.2× to 1.5×.
What is the long-term trend for Exagen Inc.'s asset turnover?
Over 5 years (2020 to 2025), Exagen Inc.'s asset turnover has grown at a 20.8% compound annual growth rate (CAGR), from 0.5× to 1.3×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.